Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies

benzinga.com/markets/equities/25/07/46364024/trump-threatens-200-pharma-tariffs-but-analyst-says-this-stock-is-immune-and-expected-to-benefit

While President Donald Trump's proposed 200% tariffs on pharmaceutical imports could potentially squeeze the profit margins, this stock is poised to “benefit” from the levies.
What Happened: Trump announced on Tuesday that the pharma tariffs, part of a Section 232 investigation launched…

This story appeared on benzinga.com, 2025-07-11 11:57:43.
The Entire Business World on a Single Page. Free to Use →